SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-156126
Filing Date
2022-05-20
Accepted
2022-05-20 16:06:05
Documents
18
Period of Report
2022-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d349292d8k.htm   iXBRL 8-K 34897
2 EX-10.1 d349292dex101.htm EX-10.1 214046
3 EX-10.2 d349292dex102.htm EX-10.2 79731
4 EX-10.3 d349292dex103.htm EX-10.3 130838
5 EX-10.4 d349292dex104.htm EX-10.4 34324
6 EX-99.1 d349292dex991.htm EX-99.1 9748
  Complete submission text file 0001193125-22-156126.txt   797529

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA celu-20220518.xsd EX-101.SCH 3894
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220518_def.xml EX-101.DEF 13667
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220518_lab.xml EX-101.LAB 22574
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220518_pre.xml EX-101.PRE 14629
12 EXTRACTED XBRL INSTANCE DOCUMENT d349292d8k_htm.xml XML 5340
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 609-235-1010
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 22947592
SIC: 2834 Pharmaceutical Preparations